Average Co-Inventor Count = 3.67
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoechst Aktiengesellschaft (19 from 6,662 patents)
2. Aventis Pharma Deutschland, Gmbh (15 from 330 patents)
34 patents:
1. 6686177 - Insulin analogs with enhanced zinc binding
2. 6476059 - Use of polycyclic 2-aminothiazole systems for the treatment of obesity
3. 6329407 - Use of polycyclic thiazole systems for the treatment of obesity
4. 6291486 - Polycyclic Dihydrothiazoles, their preparation and use as pharmaceuticals
5. 6288093 - Polycyclic thiazol-2-ylidene amines, processes for their preparation and their use as medicaments
6. 6288094 - Polycyclic thiazol-2-ylidene amines, processes for their preparation and their use as medicaments
7. 6251922 - Polycyclic 2- aminothiazole systems, processes for their preparation and pharmaceuticals comprising these compounds
8. 6235763 - Polycyclic 2-aminodihydrothiazole systems, processes for their preparation and their use as pharmaceuticals
9. 6221633 - Insulin derivatives having a rapid onset of action
10. 6221837 - Insulin derivatives with increased zinc binding
11. 6207689 - Polycyclic thiazol-2-ylidene amines, processes for their preparation and their use as medicaments
12. 6187801 - Polycyclic thiazole systems, processes for their preparation and pharmaceuticals comprising these compounds
13. 6159996 - Polycyclic thiazolidin-2-ylidene amines, process for their preparation,
14. 6156755 - Use of pyrimidine derivatives for the prevention of cancer, on their own
15. 6090833 - Polycyclic dihydrothiazoles, their preparation, and use as